Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon

Clinical Rheumatology

Volumn 25, Issue 2, 2006, Pages 153-158

  Meli, Madeleine ^a   Gitzelmann, Gabriela ^a   Koppensteiner, Renate ^a   Amann Vesti, Beatrice R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Connective tissue disease; Nailfold capillaroscopy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

FLUORESCEIN SODIUM; LA ANTIBODY; RO ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CAPILLAROSCOPY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE DURATION; FEMALE; FLUORESCENCE MICROSCOPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MIXED CONNECTIVE TISSUE DISEASE; NAIL; PREDICTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPILLARIES; CHILD; CONNECTIVE TISSUE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MICROSCOPY, VIDEO; MIDDLE AGED; NAILS; PREDICTIVE VALUE OF TESTS; RAYNAUD DISEASE;

EID: 33644856888     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-1146-1     Document Type: Article

References (35)

1. Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Franco A, Drouet P, Poncot OC, Maines MV (1993) Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs. Tarentaise, Savoie, France. J Rheumatol 20:70-76
2. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud's phenomenon: A six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634-641
3. Bennett R, Bluestone R, Holt PJ, Bywaters EG (1971) Survival in scleroderma. Ann Rheum Dis 30:581-588
4. Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 84:359-371
5. Fessel WJ (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 134:1027-1035
6. Kallenberg CG, Wouda AA, The TH (1980) Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med 69:675-680
7. Wollersheim H, Thien T, Hoet MH, Van Venrooy WJ (1989) The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur J Clin Invest 19:535-541
8. Weiner ES, Hildebrandt S, Senecal JL, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rothfield NF (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum 34:68-77
9. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155-160
10. Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183-189
11. Lee P, Sarkozi J, Bookman AA, Keystone EC, Armstrong SK (1986) Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon. J Rheumatol 13:564-569
12. Grassi W, Medico PD, Izzo F, Cervini C (2001) Microvascular involvement in systemic sclerosis: Capillaroscopic findings. Semin Arthritis Rheum 30:397-402
13. Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11:536-541
14. Passiu G, Sebastiani GD, Galeazzi M, Tuveri MA, Nicosia PM, Boirivant R (1990) Prognostic factors in Raynaud's phenomenon: Usefulness of antinuclear antibodies and of periungual capillaroscopy. Medicina (Firenze) 10:405-407
15. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023-3030
16. Brulisauer M, Bollinger A (1991) Measurement of different human microvascular dimensions by combination of videomicroscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp 10:21-31
17. Moneta G, Vollenweider U, Dubler B, Bollinger A (1986) Diagnostic value of capillaroscopy with and without fluorescent dyes to detect early connective tissue disease. Vasa 15:143-149
18. Bollinger A, Fagrell B (1990) Clinical capillaroscopy. Hogrefe, Göttingen
19. Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Junger M, Jung F, Lawall H (1997) Standardization of nailfold capillary microscopy in routine diagnosis. Vasa 26:5-10
20. Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15:894-898
21. Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328-334
22. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-407
23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558
24. Kenik JG, Maricq HR, Bole GG (1981) Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum 24:885-891
25. Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 16:619-628
26. Houtman PM, Kallenberg CG, Fidler V, Wouda AA (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 13:556-563
27. Bollinger A, Jager K, Siegenthaler W (1986) Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 146:1541-1545
28. Monticone G, Colonna L, Palermi G, Bono R, Puddu P (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects. J Am Acad Dermatol 42:787-790
29. Jacobs MJ, Breslau PJ, Slaaf DW, Reneman RS, Lemmens JA (1987) Nomenclature of Raynaud's phenomenon: A capillary microscopic and hemorheologic study. Surgery 101:136-145
30. LeRoy EC, Medsger TA Jr (1992) Raynaud's phenomenon: A proposal for classification. Clin Exp Rheumatol 10:485-488
31. Redisch W, Messina EJ, Hughes G, McEwen C (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244-253
32. Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus 11:35-41
33. Caspary L, Schmees C, Schoetensack I, Hartung K, Stannat S, Deicher H, Creutzig A, Alexander K (1991) Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. J Rheumatol 18:559-566
34. Bongard O, Bounameaux H, Miescher PA, De Moerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142-144
35. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719-726